Cargando…
An evaluation of preoperative CA 15-3 measurement in primary breast carcinoma.
In this study of 500 patients with breast carcinoma, we have prospectively assessed the role of preoperative CA 15-3 as a marker of disease burden over a 7 year period. CA 15-3 levels at presentation correlate with stage of disease, tumour size, lymph node status, the presence of metastases and lymp...
Autores principales: | O'Hanlon, D. M., Kerin, M. J., Kent, P., Maher, D., Grimes, H., Given, H. F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033858/ https://www.ncbi.nlm.nih.gov/pubmed/7779725 |
Ejemplares similares
-
Run 360P, 15 GeV/c, 5C15 R1 and R2,: Attempt to clean a stack with empty R.F. buckets
por: O'Hanlon, H
Publicado: (1973) -
Serum CA549 in primary breast cancer: comparison with CA15.3 and MCA.
por: Gion, M., et al.
Publicado: (1994) -
Serum CEA and CA 15-3 as prognostic factors in primary breast cancer
por: Ebeling, F G, et al.
Publicado: (2002) -
Association of Preoperative Serum Levels of CEA and CA15-3 with Molecular Subtypes of Breast Cancer
por: Zhao, Wenjing, et al.
Publicado: (2021) -
Symptomatic metastasis prediction with serial measurements of CA 15.3 in primary breast cancer patients
por: Bahrami-Ahmadi, Amir, et al.
Publicado: (2012)